RTW Investments manages private investment funds, including master funds, offshore funds, onshore funds, and a biotech opportunities fund, focusing primarily on the biopharmaceutical and medical technology sectors globally. The firm utilizes a scientific approach to identify and invest in transformational healthcare assets across both public and private markets, employing strategies such as equity and debt investments, direct lending, royalties, structured deals, and company incubation. RTW Investments serves institutional and sophisticated individual investors participating through its various pooled funds rather than managing individual separately managed accounts. The firm is owned and led by Dr. Roderick Wong, who serves as Managing Partner and Chief Investment Officer.
Detailed fee information is not available for this advisor. View their full brochure on SEC.gov for fee details.